MedTrace Logo

The Role of Clinical Pharmacist in Monitoring Drug Therapy in the Cardiovascular and Coronary Care Units in Libya.

NCT05531552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-07-27

No results posted yet for this study

Summary

Assessment of role of clinical pharmacist in decreasing morbidity and mortality among coronary artery disease patients.

Conditions

Interventions

DRUG

clinical pharmacy application

assessment clinical pharmacist in management of CAD and ICU patients.

Sponsors & Collaborators

  • Medical Center Hospital, libya

    collaborator UNKNOWN

  • Cairo University

    collaborator OTHER

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Asmaa S. alhomri, BCH.PH · Bachelor of Pharmaceutical Sciences, Faculty of Pharmacy, Omar Elmokhtar University, Tobruk, Libya.

  • Raghda S. Hussien, Lecturer · Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni- Suef, Egypt.

  • Eman K. Abdelall, Professor · Organic Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni- Suef, Egypt.

  • Ahmed A. Battah, Professor · Critical Care Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Eligibility

Min Age
41 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-06-30
Completion
2022-06-30
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05531552 on ClinicalTrials.gov